Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...

During a Community Case Forum event, Stacey Stein, MD, discussed data guiding the use of current regimens for the treatment ...

Koan Health, a leader in healthcare analytics, announced the upcoming release of its Financial Impact Module, a powerful new capability in its Datalysttm platform. This new module will enable ...

Bayer and Vividion Therapeutics to present latest research on their advancing oncology portfolio at AACR 2025 annual meeting: Berlin, Germany Wednesday, April 23, 2025, 10:00 Hrs ...

The week marked several FDA approvals for drugs and devices, plus data continues to show tarlatamab’s benefit in small cell lung cancer.

Mursla Bio, a Cambridge UK and Boston US leader in Extracellular Vesicle (EV) science, has received FDA approval for its lead ...

New York AI startup 1Fort secures $7.5M in funding to streamline commercial insurance for small businesses with its broker-focused platform that cuts paperwork from hours to minutes.

Coherus BioSciences is now heavily focused on developing its pipeline, particularly casdozokitug and CHS-114. See why I rate ...

California-based Tempest Therapeutics is laying off 21 of its 26 full-time employees. The cuts come while the biotech is ...

Gerry said: “I was shocked to find out that I had liver cancer, but also relieved that it had been found early and it hadn’t ...

Thinking about buying a home right now? You might want to wait. Tariff uncertainty is driving up the cost of building ...